DIAGNOS Inc. (ADK.V)
| Previous Close | 0.3400 |
| Open | 0.3400 |
| Bid | 0.3150 x 0 |
| Ask | 0.3200 x 0 |
| Day's Range | 0.3200 - 0.3400 |
| 52 Week Range | 0.1300 - 0.4300 |
| Volume | |
| Avg. Volume | 93,369 |
| Market Cap | 22.232M |
| Beta (5Y Monthly) | -0.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
DIAGNOS Announces Closing of Private Placement
BROSSARD, Quebec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the closing, today, of a non-brokered private placement (“Private Placement”) of 5 units (each a “Unit”) issued at a price of $50,000 per Unit for gross proceeds of $250,000. For the period of November 25, 2022 to this date,
- GlobeNewswire
DIAGNOS Provides Additional Information to the Closing of Private Placement
BROSSARD, Quebec, Dec. 15, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces that in connection with the closing of the private placement announced on December 12, 2022, the Corporation paid a cash commission of $9,000 to one qualified person (“Finder”) and issued 40,909 finder’s warrants to the Finde
- GlobeNewswire
DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology
Retina Scanning Retina Scanning BROSSARD, Quebec, Oct. 27, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is proud to announce it is entering the fast-growing retinal diagnostics market, armed with its new 3D image analysis technology. DIAGNOS is pushing the boundaries of the practice with a deep learni
